ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $251,266 | -20.9% | 37,594 | -0.8% | 0.00% | – |
| Q2 2023 | $317,679 | +1223.7% | 37,897 | +616.5% | 0.00% | – |
| Q1 2022 | $24,000 | +20.0% | 5,289 | +6.2% | 0.00% | – |
| Q4 2021 | $20,000 | -55.6% | 4,982 | -2.9% | 0.00% | – |
| Q3 2021 | $45,000 | -22.4% | 5,132 | 0.0% | 0.00% | – |
| Q2 2021 | $58,000 | +480.0% | 5,132 | +31.5% | 0.00% | – |
| Q1 2020 | $10,000 | -56.5% | 3,904 | 0.0% | 0.00% | – |
| Q4 2019 | $23,000 | +35.3% | 3,904 | +19.0% | 0.00% | – |
| Q3 2019 | $17,000 | -15.0% | 3,282 | 0.0% | 0.00% | – |
| Q2 2019 | $20,000 | -33.3% | 3,282 | 0.0% | 0.00% | – |
| Q1 2019 | $30,000 | +11.1% | 3,282 | 0.0% | 0.00% | – |
| Q4 2018 | $27,000 | -18.2% | 3,282 | +39.1% | 0.00% | – |
| Q3 2018 | $33,000 | +73.7% | 2,360 | 0.0% | 0.00% | – |
| Q2 2018 | $19,000 | – | 2,360 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |